跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 58,540 条关于
“PAOLA-1”
全部
58,540
临床试验
34,770
药物
7,246
机构
1,387
资讯
15,137
去年
PD-L1 Expression Correlates with HRD Status and Predicts Survival in High-Grade Serous Ovarian Cancer
2个月前
AI-Derived Biomarker From Routine Pathology Images Predicts Individual Benefit From PARP Inhibitors in Ovarian Cancer
6年前
PARP Inhibitors in Frontline Ovarian Cancer Treatment: A Review of Clinical Trials
11个月前
Long-Term Survival Data Reinforce PARP Inhibitor Benefits in BRCA-Mutated Ovarian Cancer
2个月前
PARP Inhibitors Expand Beyond BRCA-Mutated Cancers: Emerging Evidence Across Solid Tumors and Combination Strategies
2年前
Zongertinib Shows Promise in HER2-Mutated NSCLC: Boehringer Ingelheim Reports Positive Phase Ib Results
去年
Zambon Secures Chinese Approval for Intravenous Fluimucil Following Successful Phase 3 Trial
去年
CAR-T Cell Therapy with On/Off Switch Shows Promise in Preclinical Studies
2年前
Gilead's Lenacapavir Shows Promise in HIV Prevention, While GLP-1s Studied for Type 1 Diabetes
4年前
Advances in PARP Inhibitor Combinations Show Promise for Ovarian Cancer Treatment
第 1 页,共 1514 页
上一页
下一页